Express
NASDAQ-listed Medical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB
Summary: According to reports from Business Insider, NASDAQ-listed preclinical biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) announced today its plans to strategically expand into the cryptocurrency and blockchain space. The company intends to establish a subsidiary named American BNB Strategy to lead its digital asset investment and management plan. Through this platform, Liminatus plans to raise ...
According to reports from Business Insider, NASDAQ-listed preclinical biopharmaceutical company Liminatus Pharma, Inc. (NASDAQ: LIMN) announced today its plans to strategically expand into the cryptocurrency and blockchain space.
The company intends to establish a subsidiary named American BNB Strategy to lead its digital asset investment and management plan. Through this platform, Liminatus plans to raise and deploy up to $500 million in funds in stages, with the goal of strategically investing in BNB for the long term.
Liminatus emphasizes that while the company remains fully committed to its core business of advancing cancer treatment and pancreatic cancer diagnostic technologies, expanding into the digital asset space is seen as a necessary step to support long-term growth and enhance shareholder value.
Liminatus is a preclinical biopharmaceutical company dedicated to developing immunotherapies for cancer patients. The company is advancing a series of novel therapies targeting cancer antigens and tumor-specific immune responses.
Tags:
Link: NASDAQ-listed Medical Company Liminatus Pharma Plans to Raise $500 Million to Invest in BNB [Copy]
